MannKind Corporation (MNKD) vs Tyra Biosciences, Inc. (TYRA)

A side-by-side comparison of MannKind Corporation and Tyra Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MNKD vs TYRA

growth of $100 · dividends reinvested · last 5y
MNKD -18.2% (-3.9%/yr)TYRA -19.5% (-4.2%/yr)MNKD compounded faster over this window
50100150Start $10020222023202420252026$82$81
MNKD TYRA

MNKD vs TYRA: by the numbers

  • •MNKD is the larger company ($1.21B vs $1.20B market cap).
  • •Both run net losses; TYRA's is the smaller (0.00% vs -11.08% net margin).

Metrics side by side

Valuation

MetricMNKDTYRA
P/S ratio3.07N/A
P/B ratioN/A3.40
EV / EBITDA52.09N/A

Profitability

MetricMNKDTYRA
Gross margin75.69%0.00%
Operating margin11.12%0.00%
Net margin-11.08%0.00%
ROEN/A-42.01%
ROIC1.32%-44.73%

Growth (annualized)

MetricMNKDTYRA
Revenue CAGR (5Y)39.51%N/A
Total return CAGR (5Y)-4.18%9.23%

Frequently asked

How have MNKD and TYRA total returns compared?
Over the past 5 years, MNKD delivered -4.18% and TYRA delivered 9.23% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.